Literature DB >> 2170273

Angiotensin I converting enzyme and the changes in our concepts through the years. Lewis K. Dahl memorial lecture.

E G Erdös1.   

Abstract

Changes in our concepts of angiotensin I converting enzyme are reviewed briefly. The actions of this enzyme go beyond liberating angiotensin II from angiotensin I or inactivating bradykinin. Its very wide distribution in the body and its activity in vitro indicate involvement in the metabolism of other biologically active peptides. The recent molecular cloning of the human enzyme confirmed the existence of a hydrophobic C-terminal peptide that forms the short transmembrane domain of this plasma membrane-bound enzyme. The much longer external portion contains two homologous active site domains but probably only one functional active center. Finally, in spite of the great progress made in studying angiotensin converting enzyme, there are many challenging problems waiting to be solved.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2170273     DOI: 10.1161/01.hyp.16.4.363

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  67 in total

Review 1.  Targeted endothelial nanomedicine for common acute pathological conditions.

Authors:  Vladimir V Shuvaev; Jacob S Brenner; Vladimir R Muzykantov
Journal:  J Control Release       Date:  2015-10-03       Impact factor: 9.776

Review 2.  GPI-AP release in cellular, developmental, and reproductive biology.

Authors:  Yoshitaka Fujihara; Masahito Ikawa
Journal:  J Lipid Res       Date:  2015-11-22       Impact factor: 5.922

3.  Review: Intrarenal angiotensin II levels in normal and hypertensive states.

Authors:  L Gabriel Navar; Kenneth D Mitchell; Lisa M Harrison-Bernard; Hiroyuki Kobori; Akira Nishiyama
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2001-03       Impact factor: 1.636

Review 4.  Interacting cogs in the machinery of the renin angiotensin system.

Authors:  Lizelle Lubbe; Edward D Sturrock
Journal:  Biophys Rev       Date:  2019-06-08

5.  Association of the TNF-alpha-308 (G-->A) polymorphism with self-reported history of childhood asthma.

Authors:  E C Winchester; I Y Millwood; L Rand; M A Penny; A M Kessling
Journal:  Hum Genet       Date:  2000-12       Impact factor: 4.132

6.  A novel peptide-processing activity of insect peptidyl-dipeptidase A (angiotensin I-converting enzyme): the hydrolysis of lysyl-arginine and arginyl-arginine from the C-terminus of an insect prohormone peptide.

Authors:  R Isaac; L Schoofs; T A Williams; D Veelaert; M Sajid; P Corvol; D Coates
Journal:  Biochem J       Date:  1998-02-15       Impact factor: 3.857

7.  The effect of high plasma levels of angiotensin-converting enzyme (ACE) and plasminogen activator inhibitor (PAI-1) on the reperfusion after thrombolytic therapy in patients presented with acute myocardial infarction.

Authors:  Ayman A El Menyar; O M Altamimi; Mohamed M Gomaa; Zainab Fawzy; M O Abdel Rahman; Abdulbari Bener
Journal:  J Thromb Thrombolysis       Date:  2006-06       Impact factor: 2.300

8.  In vivo bradykinin B2 receptor activation reduces renal fibrosis.

Authors:  Joost P Schanstra; Eric Neau; Pascale Drogoz; Miguel A Arevalo Gomez; José Miguel Lopez Novoa; Denis Calise; Christiane Pecher; Michael Bader; Jean-Pierre Girolami; Jean-Loup Bascands
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808

9.  Effects of angiotensin II generated by an angiotensin converting enzyme-independent pathway on left ventricular performance in the conscious baboon.

Authors:  B D Hoit; Y Shao; A Kinoshita; M Gabel; A Husain; R A Walsh
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

10.  Angiotensin converting enzyme binding sites in human heart and lung: comparison with rat tissues.

Authors:  T Vago; M Bevilacqua; F Conci; G Baldi; E Ongini; E Chebat; A Monopoli; G Norbiato
Journal:  Br J Pharmacol       Date:  1992-11       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.